Myraquat

Foundation date

14/04/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Myraquat develops therapeutic compounds acting as membrane modulators to control pathogenic microorganisms.

Latest news

  • Antonin (Tony) de Fougerolles appointed as new Chair of etherna

    Tuesday July 16th 2024

  • ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust

    Tuesday July 16th 2024

  • Ghent University spin-off Trince wins Nature Spinoff Prize

    Monday July 15th 2024